Hologic, Inc. (HOLX)

NASDAQ: HOLX · Real-Time Price · USD
68.34
+0.61 (0.90%)
At close: Oct 8, 2025, 4:00 PM EDT
68.45
+0.11 (0.16%)
After-hours: Oct 8, 2025, 6:43 PM EDT
0.90%
Market Cap15.20B
Revenue (ttm)4.04B
Net Income (ttm)557.10M
Shares Out 222.42M
EPS (ttm)2.41
PE Ratio28.31
Forward PE15.50
Dividendn/a
Ex-Dividend Daten/a
Volume1,116,637
Open67.62
Previous Close67.73
Day's Range67.15 - 68.38
52-Week Range51.90 - 84.39
Beta0.63
AnalystsBuy
Price Target78.92 (+15.48%)
Earnings DateNov 3, 2025

About HOLX

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos... [Read more]

Sector Healthcare
IPO Date Jun 21, 1990
Employees 7,063
Stock Exchange NASDAQ
Ticker Symbol HOLX
Full Company Profile

Financial Performance

In 2024, Hologic's revenue was $4.03 billion, a decrease of -0.00% compared to the previous year's $4.03 billion. Earnings were $789.50 million, an increase of 73.14%.

Financial Statements

Analyst Summary

According to 14 analysts, the average rating for HOLX stock is "Buy." The 12-month stock price target is $78.92, which is an increase of 15.48% from the latest price.

Price Target
$78.92
(15.48% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025.

6 days ago - Business Wire

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #Bacterial--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Panther Fus...

6 days ago - Business Wire

New Survey Results Underscore the Need to #BustTheMyth About Mammograms

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #BCAM--New Survey Results Underscore the Need to #BustTheMyth About Mammograms.

8 days ago - Business Wire

Volition Signs Co-Marketing and Services Agreement with Hologic

HENDERSON, Nev. , Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with Holog...

Other symbols: VNRX
9 days ago - PRNewsWire

Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

HAUPPAUGE, N.Y. , Sept. 29, 2025 /PRNewswire/ -- Minicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation of ...

9 days ago - PRNewsWire

New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #AI--New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI.

12 days ago - Business Wire

Blackstone and TPG revive interest in buying Hologic, source says

Private equity firms Blackstone and TPG revived their interest in acquiring medical device maker Hologic , a person close to the transaction said on Wednesday.

Other symbols: BXTPG
21 days ago - Reuters

Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Hologic, Inc. (NASDAQ:HOLX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:45 AM EDT Company Participants Stephen MacMillan - Chairman, CEO & President Conference Call P...

4 weeks ago - Seeking Alpha

Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference.

5 weeks ago - Business Wire

Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript

Hologic, Inc. (NASDAQ:HOLX) Q3 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Essex D. Mitchell - Chief Operating Officer Karleen M.

2 months ago - Seeking Alpha

Hologic raises annual profit forecast on diagnostic and surgical demand

Medical equipment maker Hologic on Wednesday raised its annual profit forecast, anticipating strong demand for its molecular diagnostic devices and surgical products.

2 months ago - Reuters

Hologic Announces Financial Results for Third Quarter of Fiscal 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Financial Results for Third Quarter of Fiscal 2025.

2 months ago - Business Wire

Hologic Q3 Preview: Tariff Pressure And Undervalued Stock Price, Initiate With Buy

I am initiating a Buy rating on Hologic, Inc. with a fair value of $81, as current risks are priced in. Hologic's strong diagnostic portfolio, recurring consumables revenue, and expanding assay menu s...

2 months ago - Seeking Alpha

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025.

3 months ago - Business Wire

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

ARLINGTON, Va.--(BUSINESS WIRE)--NEST, an initiative of MDIC, is pleased to welcome Hologic, a leading global medical device company, to its Governance Committee.

4 months ago - Business Wire

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

Private equity firms TPG and Blackstone BX recently bid to acquire Hologic Inc. HOLX, valuing the U.S. medical technology company at over $16 billion.

4 months ago - Benzinga

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

Medical equipment maker Hologic rejected a $16 billion non-binding offer from private equity firms TPG and Blackstone , the Financial Times reported on Tuesday, citing people familiar with the matter.

Other symbols: BXTPG
4 months ago - Reuters

Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #ASCO--Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test.

4 months ago - Business Wire

Hologic to Webcast Presentations at Upcoming Investor Conferences

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic to Webcast Presentations at Upcoming Investor Conferences.

5 months ago - Business Wire

Hologic: Soft Performance, But Cheap Enough

Hologic, Inc.'s appeal has increased due to reduced debt, serial buybacks, and modest valuations, despite recent negative organic growth and pricey acquisitions. The company has shown solid long-term ...

5 months ago - Seeking Alpha

Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript

Hologic, Inc. (NASDAQ:HOLX) Q2 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Mike Watts - Corporate VP, IR Steve MacMillan - Chairman, President & CEO Essex Mitchell - COO...

5 months ago - Seeking Alpha

Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty

Medical equipment maker Hologic lowered its fiscal 2025 profit forecast, citing uncertainty around the tariffs imposed by U.S. President Donald Trump's administration, sending the company's shares dow...

5 months ago - Reuters

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Financial Results for Second Quarter of Fiscal 2025.

5 months ago - Business Wire

Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players - Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & More

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Cellulite Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com...

5 months ago - GlobeNewsWire

Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #AI--Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI.

5 months ago - Business Wire